UK launches world’s first ‘subscription-style’ payment model for antibiotics
The scheme could give NHS patients access to new antibiotics as early as 2022
Read More
Tag: payment
Gilead, Galapagos form $5.1b R&D partnership
Galapagos will receive a $3.95 billion upfront payment and a $1.1 billion equity investment from Gilead, which it will use to expand and accelerate its research and development programs.
Read More
AMR pushes NHS to trial ‘subscription-style’ payment model
Companies are set to be paid based on the value the medicine brings to the NHS.
Read More
Sosei Heptares to get $3m Pfizer milestone payment
The deal was initially signed in November 2015 to research and develop potential new medicines directed at up to ten GPCR targets across multiple therapeutic areas.
Read More
- MRM Health collaborates with Oncode Institute and Netherlands Cancer Institute
- Sobi to acquire Arthrosi Therapeutics, strengthening gout treatment pipeline
- Lindus Health and Quotient Sciences announce strategic partnership to accelerate drug development
- Title21 Health Solutions joins the Blood and Cells Advocacy Roster
- NADMED launches $30,000 metabolomics research award
